Associated Papers
Synchronous T-lymphoblastic lymphoma and neuroblastoma in a 3-yr-old with novel germline SMARCA4 and EZH2 variants.
Tibout P et al.
Cold Spring Harbor Molecular Case Studies, 2023
Investigation of PALB2 Mutation and Correlation With Immunotherapy Biomarker in Chinese Non-Small Cell Lung Cancer Patients.
Zhang J et al.
Frontiers in Oncology, 2021
35087742 (PubMed )
Supplement: Table_1.xlsx › Table3_mut_frequency_v3
Notch activation leads to loss of myoepithelial differentiation and poor outcome in solid adenoid cystic carcinoma.
Zhang Y et al.
Oral Diseases, 2020
Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.
Sajed DP et al.
The American Journal of Surgical Pathology, 2017
Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
Ferrarotto R et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2017
Select a paper to view details